Development and evaluation of nasal formulations of ketorolac

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 7, Issue 4, 2000, Pages 223-229

  Quadir, M ^a   Zia, H ^a   Needham, T E ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Bioadhesive Polymer; Ketorolac Acid; Ketorolac Tromethamine; Microcrystalline Cellulose; Nasal Powder; Nasal Spray

Indexed keywords

KETOROLAC; KETOROLAC TROMETAMOL; MICROCRYSTALLINE CELLULOSE; POLYSORBATE 80;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRY POWDER; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NOSE CAVITY; NOSE MUCOSA; PRIORITY JOURNAL; RABBIT;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CELLULOSE; EXCIPIENTS; INJECTIONS, INTRAVENOUS; KETOROLAC TROMETHAMINE; MALE; MICROSPHERES; PARTICLE SIZE; RABBITS;

EID: 0034525585     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175400455155     Document Type: Article

References (36)

1. 99m instilled intranasally
2. 18) in processing plasma for analysis of indomethacin by high performance liquid chromatography
3. Deposition and clearance of nasal sprays
4. Ketorolac: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential
5. Ketorolac as a rapid and effective treatment of migraine headache: Evaluation by patients
6. The use of ketorolac in the management of postoperative pain
7. In vivo evaluation of spray formulations of human insulin for nasal delivery
8. Preparation and in vitro characterization of mucoadhesive polymeric microspheres as intranasal delivery systems
9. Animal models for intranasal drug delivery studies
10. Kinetics and mechanisms of the autoxidation of ketorolac tromethamine in aqueous solution
11. Intranasal drug delivery by spray and drops
12. Effect of viscosity on the particle size, deposition and clearance of nasal delivery systems containing desmopressin
13. Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin
14. A randomized double-blind comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine
15. Intranasal bioavailability of insulin powder formulations: Effect of permeation enhancer-toprotein ratio
16. Intranasal gelling delivery systems: A viscoelasticity analysis of nasal residence time
17. Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbit
18. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity
19. Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel
20. Effects of viscous hyaluronate sodium solutions on the nasal absorption of vasopressin and an analogue
21. Ketorolac tromethamine absorption, distribution, metabolism, excretion, and pharmacokinetics in animals and humans
22. Regeneration of rabbit olfactory epithelium
23. Powder dosage form of insulin for nasal administration
24. Deposition pattern from a nasal pump spray
25. Effects of dose, pH, and osmolarity on nasal absorption of secretin in rats. II. Histological aspects of the nasal mucosa in relation to the absorption variation due to the effects of pH and osmolarity
26. Scanning electron microscopy of the nasal mucous membrane
27. The influence of solution viscosity on nasal spray deposition and clearance
28. Surface interfacial and molecular aspects of polymer bioadhesion on soft tissues
29. Permeability of ketorolac acid and its ester analogs (Prodrug) through human cadaver skin
30. Nasal formulations of ketorolac tromethamine, technogical evaluation - Bioavailability and tolerability in rabbits
31. Percutaneous absorption of nicaripine and ketorolac in rhesus monkeys
32. Ketorolac tromethamine and ketoprofen suppositories: Release profiles and bioavailability of a cocoa butter base formula in rabbits